Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Panax | 57 | 2017 | 170 | 13.760 |
Why?
|
Plant Extracts | 64 | 2017 | 244 | 12.340 |
Why?
|
Phytotherapy | 42 | 2016 | 136 | 10.020 |
Why?
|
Ginsenosides | 39 | 2016 | 123 | 9.170 |
Why?
|
Antineoplastic Agents, Phytogenic | 25 | 2016 | 277 | 6.970 |
Why?
|
Naltrexone | 24 | 2013 | 136 | 4.310 |
Why?
|
Narcotic Antagonists | 24 | 2013 | 157 | 4.280 |
Why?
|
Colorectal Neoplasms | 30 | 2014 | 980 | 3.910 |
Why?
|
Drugs, Chinese Herbal | 19 | 2015 | 67 | 3.560 |
Why?
|
Flavonoids | 12 | 2015 | 87 | 2.990 |
Why?
|
Chromatography, High Pressure Liquid | 23 | 2016 | 315 | 2.980 |
Why?
|
Panax notoginseng | 7 | 2016 | 23 | 2.830 |
Why?
|
Apoptosis | 34 | 2016 | 1715 | 2.820 |
Why?
|
Cell Proliferation | 27 | 2015 | 1649 | 2.710 |
Why?
|
Oplopanax | 7 | 2014 | 29 | 2.700 |
Why?
|
Plant Roots | 28 | 2017 | 107 | 2.590 |
Why?
|
Antioxidants | 13 | 2014 | 224 | 2.570 |
Why?
|
Saponins | 13 | 2016 | 42 | 2.520 |
Why?
|
Sapogenins | 7 | 2016 | 24 | 2.440 |
Why?
|
Colonic Neoplasms | 8 | 2017 | 573 | 2.280 |
Why?
|
Fruit | 13 | 2011 | 76 | 2.210 |
Why?
|
Cell Cycle | 19 | 2015 | 509 | 2.060 |
Why?
|
Fluorouracil | 8 | 2015 | 561 | 2.060 |
Why?
|
Plants, Medicinal | 12 | 2014 | 42 | 1.970 |
Why?
|
Hypoglycemic Agents | 12 | 2014 | 348 | 1.960 |
Why?
|
Scutellaria baicalensis | 9 | 2015 | 26 | 1.820 |
Why?
|
Analgesics, Opioid | 13 | 2013 | 442 | 1.760 |
Why?
|
Animals | 92 | 2017 | 27274 | 1.580 |
Why?
|
Flavanones | 8 | 2015 | 35 | 1.550 |
Why?
|
Brain Stem | 11 | 2004 | 167 | 1.530 |
Why?
|
Pica | 6 | 2007 | 14 | 1.520 |
Why?
|
Morphine | 11 | 2004 | 130 | 1.510 |
Why?
|
Mass Spectrometry | 4 | 2016 | 193 | 1.510 |
Why?
|
Blood Glucose | 12 | 2014 | 836 | 1.410 |
Why?
|
Vitis | 7 | 2011 | 19 | 1.400 |
Why?
|
Myocytes, Cardiac | 8 | 2011 | 313 | 1.360 |
Why?
|
Constipation | 7 | 2013 | 63 | 1.360 |
Why?
|
Cell Line, Tumor | 29 | 2014 | 2549 | 1.350 |
Why?
|
Anticarcinogenic Agents | 5 | 2013 | 73 | 1.340 |
Why?
|
Solitary Nucleus | 11 | 2004 | 21 | 1.340 |
Why?
|
Colitis | 4 | 2017 | 244 | 1.280 |
Why?
|
Oxidative Stress | 9 | 2008 | 456 | 1.270 |
Why?
|
Leptin | 6 | 2009 | 102 | 1.250 |
Why?
|
Stomach | 9 | 2004 | 111 | 1.250 |
Why?
|
HCT116 Cells | 15 | 2015 | 155 | 1.240 |
Why?
|
Drug Synergism | 12 | 2015 | 305 | 1.220 |
Why?
|
Quaternary Ammonium Compounds | 23 | 2013 | 80 | 1.190 |
Why?
|
Plant Preparations | 3 | 2016 | 21 | 1.170 |
Why?
|
Gastrointestinal Microbiome | 4 | 2017 | 501 | 1.110 |
Why?
|
Antimetabolites, Antineoplastic | 4 | 2015 | 237 | 1.110 |
Why?
|
Biological Products | 4 | 2014 | 151 | 1.100 |
Why?
|
Antineoplastic Agents | 13 | 2014 | 2410 | 1.070 |
Why?
|
Neurons | 10 | 2016 | 1576 | 1.040 |
Why?
|
Gastrointestinal Transit | 9 | 2005 | 19 | 1.040 |
Why?
|
Smilax | 2 | 2015 | 5 | 0.990 |
Why?
|
Carcinogenesis | 2 | 2017 | 211 | 0.990 |
Why?
|
Mice | 32 | 2017 | 11722 | 0.980 |
Why?
|
Hyperuricemia | 2 | 2015 | 24 | 0.970 |
Why?
|
Obesity | 8 | 2011 | 964 | 0.960 |
Why?
|
Cisplatin | 7 | 2006 | 617 | 0.950 |
Why?
|
Dose-Response Relationship, Drug | 21 | 2013 | 1938 | 0.940 |
Why?
|
Neoplasms | 7 | 2016 | 3020 | 0.910 |
Why?
|
Humans | 98 | 2016 | 88875 | 0.910 |
Why?
|
Chromatography, Liquid | 2 | 2016 | 106 | 0.910 |
Why?
|
Vomiting | 7 | 2012 | 194 | 0.890 |
Why?
|
Proanthocyanidins | 5 | 2011 | 12 | 0.850 |
Why?
|
Rats | 25 | 2012 | 4039 | 0.830 |
Why?
|
Narcotics | 5 | 2006 | 70 | 0.820 |
Why?
|
Drug Contamination | 2 | 2014 | 12 | 0.820 |
Why?
|
Disease Models, Animal | 18 | 2016 | 2347 | 0.810 |
Why?
|
Reishi | 3 | 2007 | 7 | 0.810 |
Why?
|
Purkinje Fibers | 5 | 2001 | 27 | 0.800 |
Why?
|
Reactive Oxygen Species | 13 | 2014 | 487 | 0.790 |
Why?
|
Nausea | 7 | 2012 | 176 | 0.750 |
Why?
|
Rats, Sprague-Dawley | 17 | 2014 | 1236 | 0.740 |
Why?
|
Gastrointestinal Motility | 4 | 2006 | 25 | 0.730 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2011 | 1174 | 0.720 |
Why?
|
Pain | 5 | 2004 | 400 | 0.720 |
Why?
|
Body Weight | 10 | 2013 | 452 | 0.720 |
Why?
|
Free Radical Scavengers | 5 | 2013 | 59 | 0.700 |
Why?
|
Injections, Intraperitoneal | 11 | 2011 | 101 | 0.680 |
Why?
|
Breast Neoplasms | 6 | 2013 | 2991 | 0.680 |
Why?
|
Oxidants | 6 | 2007 | 86 | 0.680 |
Why?
|
Mice, Obese | 10 | 2011 | 43 | 0.660 |
Why?
|
Male | 52 | 2017 | 42147 | 0.650 |
Why?
|
Medicine, Chinese Traditional | 3 | 2012 | 9 | 0.640 |
Why?
|
Reperfusion Injury | 2 | 2011 | 140 | 0.600 |
Why?
|
Caspases | 5 | 2013 | 155 | 0.600 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2009 | 191 | 0.600 |
Why?
|
Cell Survival | 12 | 2010 | 981 | 0.590 |
Why?
|
Antiemetics | 5 | 2007 | 98 | 0.580 |
Why?
|
Diynes | 2 | 2013 | 7 | 0.550 |
Why?
|
Fatty Alcohols | 2 | 2013 | 10 | 0.550 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 105 | 0.550 |
Why?
|
Herbal Medicine | 3 | 2012 | 8 | 0.540 |
Why?
|
Dietary Supplements | 4 | 2005 | 125 | 0.540 |
Why?
|
Phenols | 2 | 2006 | 41 | 0.540 |
Why?
|
Azoxymethane | 4 | 2017 | 84 | 0.530 |
Why?
|
Hydrogen Peroxide | 6 | 2008 | 159 | 0.520 |
Why?
|
Hot Temperature | 4 | 2013 | 208 | 0.520 |
Why?
|
Crocus | 2 | 2013 | 3 | 0.520 |
Why?
|
Catechin | 2 | 2012 | 24 | 0.510 |
Why?
|
Mice, Nude | 6 | 2015 | 814 | 0.510 |
Why?
|
Dextran Sulfate | 4 | 2017 | 68 | 0.510 |
Why?
|
Plant Leaves | 5 | 2006 | 77 | 0.500 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.490 |
Why?
|
Allopurinol | 1 | 2015 | 77 | 0.490 |
Why?
|
Glycosides | 1 | 2014 | 20 | 0.490 |
Why?
|
Uricosuric Agents | 1 | 2014 | 11 | 0.480 |
Why?
|
Animals, Newborn | 9 | 2009 | 524 | 0.480 |
Why?
|
Cell Death | 3 | 2013 | 262 | 0.480 |
Why?
|
Complementary Therapies | 3 | 2010 | 56 | 0.480 |
Why?
|
Diabetes Mellitus | 5 | 2005 | 738 | 0.480 |
Why?
|
Daphne | 1 | 2014 | 9 | 0.480 |
Why?
|
Glucose Tolerance Test | 8 | 2014 | 227 | 0.470 |
Why?
|
Chick Embryo | 9 | 2009 | 230 | 0.470 |
Why?
|
Vagus Nerve | 4 | 2004 | 49 | 0.470 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2013 | 29 | 0.470 |
Why?
|
Arthritis, Experimental | 1 | 2014 | 26 | 0.460 |
Why?
|
Genistein | 1 | 2013 | 16 | 0.450 |
Why?
|
Seeds | 5 | 2009 | 49 | 0.450 |
Why?
|
NF-kappa B | 3 | 2014 | 465 | 0.450 |
Why?
|
Steroids | 1 | 2014 | 174 | 0.440 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2013 | 409 | 0.440 |
Why?
|
Structure-Activity Relationship | 6 | 2016 | 411 | 0.440 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 55 | 0.440 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2015 | 470 | 0.430 |
Why?
|
Bufanolides | 3 | 2001 | 5 | 0.420 |
Why?
|
Rats, Wistar | 7 | 2007 | 302 | 0.410 |
Why?
|
Plant Stems | 2 | 2009 | 9 | 0.410 |
Why?
|
Mitochondria | 2 | 2013 | 551 | 0.410 |
Why?
|
Bile | 1 | 2012 | 57 | 0.410 |
Why?
|
Herb-Drug Interactions | 1 | 2011 | 4 | 0.400 |
Why?
|
Chemoprevention | 4 | 2013 | 92 | 0.400 |
Why?
|
Administration, Oral | 9 | 2011 | 682 | 0.400 |
Why?
|
Cardiotonic Agents | 3 | 2001 | 89 | 0.390 |
Why?
|
Cold Temperature | 5 | 2004 | 160 | 0.390 |
Why?
|
Molecular Structure | 5 | 2015 | 288 | 0.390 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 343 | 0.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 2550 | 0.380 |
Why?
|
Mice, Inbred C57BL | 10 | 2012 | 3202 | 0.380 |
Why?
|
Camptothecin | 1 | 2012 | 193 | 0.380 |
Why?
|
Publishing | 1 | 2012 | 90 | 0.370 |
Why?
|
Methadone | 3 | 2000 | 45 | 0.370 |
Why?
|
Flow Cytometry | 5 | 2010 | 690 | 0.370 |
Why?
|
Cyclin A | 4 | 2013 | 29 | 0.360 |
Why?
|
Antimycin A | 3 | 2006 | 13 | 0.350 |
Why?
|
Drug Interactions | 7 | 2012 | 245 | 0.340 |
Why?
|
Intra-Abdominal Fat | 1 | 2009 | 32 | 0.340 |
Why?
|
Biological Availability | 3 | 2016 | 92 | 0.340 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 1428 | 0.340 |
Why?
|
Araliaceae | 1 | 2009 | 2 | 0.340 |
Why?
|
Adiposity | 1 | 2009 | 76 | 0.340 |
Why?
|
Coronary Disease | 1 | 2011 | 260 | 0.340 |
Why?
|
Double-Blind Method | 10 | 2014 | 1713 | 0.340 |
Why?
|
Cells, Cultured | 9 | 2007 | 2879 | 0.330 |
Why?
|
Signal Transduction | 4 | 2014 | 3370 | 0.330 |
Why?
|
Gastric Emptying | 3 | 2008 | 25 | 0.320 |
Why?
|
Weight Gain | 1 | 2009 | 119 | 0.320 |
Why?
|
Female | 28 | 2014 | 45912 | 0.320 |
Why?
|
Eating | 3 | 2009 | 165 | 0.320 |
Why?
|
Muscimol | 4 | 2004 | 19 | 0.320 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 1399 | 0.320 |
Why?
|
GABA Antagonists | 4 | 2004 | 25 | 0.320 |
Why?
|
Baclofen | 3 | 2004 | 15 | 0.310 |
Why?
|
Weight Loss | 1 | 2009 | 225 | 0.310 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 21 | 0.300 |
Why?
|
Cell Division | 2 | 2006 | 696 | 0.300 |
Why?
|
Ritonavir | 1 | 2007 | 12 | 0.300 |
Why?
|
Carotenoids | 1 | 2007 | 15 | 0.300 |
Why?
|
Heart | 2 | 2002 | 573 | 0.300 |
Why?
|
Intestinal Mucosa | 3 | 2014 | 805 | 0.290 |
Why?
|
Central Nervous System Agents | 3 | 2001 | 15 | 0.290 |
Why?
|
Valerian | 2 | 2004 | 3 | 0.290 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2001 | 65 | 0.280 |
Why?
|
Receptors, Opioid, mu | 2 | 2013 | 45 | 0.270 |
Why?
|
Cholesterol | 2 | 2006 | 356 | 0.270 |
Why?
|
Murraya | 1 | 2006 | 2 | 0.270 |
Why?
|
Kava | 2 | 2002 | 3 | 0.270 |
Why?
|
Flowers | 3 | 2014 | 37 | 0.270 |
Why?
|
Electrophysiology | 6 | 2004 | 403 | 0.270 |
Why?
|
Area Under Curve | 5 | 2005 | 337 | 0.260 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2013 | 78 | 0.260 |
Why?
|
Kaolin | 4 | 2007 | 9 | 0.260 |
Why?
|
Nitric Oxide | 4 | 2014 | 279 | 0.260 |
Why?
|
Adult | 21 | 2016 | 26440 | 0.250 |
Why?
|
Platelet Activation | 1 | 2005 | 14 | 0.250 |
Why?
|
Angelica | 1 | 2004 | 2 | 0.250 |
Why?
|
Organic Anion Transport Protein 1 | 2 | 2015 | 4 | 0.250 |
Why?
|
Glucose Transport Proteins, Facilitative | 2 | 2015 | 5 | 0.250 |
Why?
|
Corydalis | 1 | 2004 | 4 | 0.250 |
Why?
|
Strophanthidin | 2 | 2001 | 3 | 0.250 |
Why?
|
Polyphenols | 3 | 2012 | 13 | 0.250 |
Why?
|
Organic Anion Transporters | 2 | 2015 | 26 | 0.250 |
Why?
|
Cell Cycle Checkpoints | 3 | 2013 | 66 | 0.240 |
Why?
|
Cholecystokinin | 2 | 2002 | 15 | 0.240 |
Why?
|
Blood Coagulation | 1 | 2005 | 92 | 0.240 |
Why?
|
Gastrointestinal Diseases | 1 | 2006 | 150 | 0.240 |
Why?
|
Uric Acid | 2 | 2015 | 136 | 0.240 |
Why?
|
Digestive System | 2 | 2001 | 42 | 0.240 |
Why?
|
Sesquiterpenes | 1 | 2004 | 13 | 0.240 |
Why?
|
Indenes | 1 | 2004 | 10 | 0.240 |
Why?
|
Ephedra sinica | 1 | 2004 | 1 | 0.240 |
Why?
|
Receptors, GABA | 1 | 2004 | 11 | 0.240 |
Why?
|
Scutellaria | 1 | 2004 | 3 | 0.240 |
Why?
|
Mitochondria, Heart | 2 | 2002 | 50 | 0.230 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 403 | 0.230 |
Why?
|
Warfarin | 1 | 2004 | 104 | 0.230 |
Why?
|
Colon | 4 | 2013 | 509 | 0.220 |
Why?
|
Gymnema | 1 | 2003 | 1 | 0.220 |
Why?
|
Heterografts | 2 | 2014 | 102 | 0.220 |
Why?
|
G2 Phase Cell Cycle Checkpoints | 2 | 2013 | 12 | 0.220 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2004 | 69 | 0.220 |
Why?
|
Electroacupuncture | 1 | 2003 | 1 | 0.220 |
Why?
|
Risk | 3 | 2013 | 657 | 0.220 |
Why?
|
Pyrones | 1 | 2002 | 8 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 1113 | 0.220 |
Why?
|
GABA Agents | 1 | 2002 | 8 | 0.220 |
Why?
|
Nucleus Accumbens | 1 | 2004 | 113 | 0.220 |
Why?
|
Myocardium | 3 | 2002 | 571 | 0.220 |
Why?
|
Lactones | 1 | 2002 | 27 | 0.220 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2014 | 85 | 0.210 |
Why?
|
Acupressure | 1 | 2002 | 1 | 0.210 |
Why?
|
Arrhythmias, Cardiac | 2 | 2001 | 197 | 0.210 |
Why?
|
Pain Threshold | 1 | 2003 | 61 | 0.210 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2002 | 15 | 0.210 |
Why?
|
Cell Hypoxia | 2 | 2002 | 170 | 0.210 |
Why?
|
Digestive System Physiological Phenomena | 1 | 2002 | 4 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 1265 | 0.210 |
Why?
|
China | 2 | 2014 | 232 | 0.210 |
Why?
|
Galanin | 1 | 2002 | 6 | 0.210 |
Why?
|
Receptors, Opioid | 2 | 2006 | 23 | 0.210 |
Why?
|
Gene Expression | 3 | 2013 | 1310 | 0.210 |
Why?
|
Breath Tests | 5 | 2002 | 57 | 0.210 |
Why?
|
Anti-Obesity Agents | 1 | 2002 | 13 | 0.200 |
Why?
|
Peripheral Nervous System | 1 | 2002 | 21 | 0.200 |
Why?
|
Cardiac Glycosides | 1 | 2001 | 5 | 0.200 |
Why?
|
Digoxin | 1 | 2001 | 21 | 0.200 |
Why?
|
Electric Stimulation | 5 | 2004 | 354 | 0.190 |
Why?
|
G1 Phase | 2 | 2012 | 65 | 0.190 |
Why?
|
Pain Management | 1 | 2003 | 137 | 0.190 |
Why?
|
In Vitro Techniques | 5 | 2003 | 996 | 0.190 |
Why?
|
Lamiaceae | 1 | 2001 | 2 | 0.190 |
Why?
|
Kidney | 3 | 2015 | 1145 | 0.190 |
Why?
|
Sodium Channel Blockers | 1 | 2001 | 27 | 0.190 |
Why?
|
Analgesics, Non-Narcotic | 2 | 1998 | 48 | 0.190 |
Why?
|
Acetaminophen | 2 | 1998 | 56 | 0.190 |
Why?
|
Anticoagulants | 1 | 2004 | 426 | 0.190 |
Why?
|
Enkephalins | 2 | 1999 | 16 | 0.180 |
Why?
|
Gastric Mucosa | 1 | 2000 | 66 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 340 | 0.180 |
Why?
|
North America | 2 | 2011 | 183 | 0.180 |
Why?
|
Amphibian Venoms | 1 | 2000 | 1 | 0.180 |
Why?
|
Myocardial Contraction | 1 | 2001 | 252 | 0.180 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 704 | 0.180 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2000 | 52 | 0.170 |
Why?
|
HT29 Cells | 2 | 2009 | 50 | 0.170 |
Why?
|
Analysis of Variance | 4 | 2004 | 901 | 0.170 |
Why?
|
Calibration | 2 | 2014 | 104 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 666 | 0.170 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2000 | 202 | 0.170 |
Why?
|
Perioperative Care | 1 | 2001 | 168 | 0.170 |
Why?
|
Receptors, Opioid, delta | 1 | 1999 | 7 | 0.170 |
Why?
|
Receptors, Opioid, kappa | 1 | 1999 | 15 | 0.170 |
Why?
|
Reproducibility of Results | 3 | 2016 | 2751 | 0.170 |
Why?
|
Naloxone | 3 | 2009 | 64 | 0.170 |
Why?
|
Polysaccharides | 3 | 2006 | 90 | 0.170 |
Why?
|
Endothelins | 1 | 1999 | 26 | 0.160 |
Why?
|
Brain | 2 | 2001 | 2269 | 0.160 |
Why?
|
Time Factors | 6 | 2009 | 5313 | 0.160 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1998 | 15 | 0.160 |
Why?
|
GABA Modulators | 1 | 1998 | 8 | 0.160 |
Why?
|
Thrombin | 1 | 1999 | 61 | 0.160 |
Why?
|
Anti-HIV Agents | 1 | 2001 | 155 | 0.160 |
Why?
|
Ion Channel Gating | 1 | 2001 | 325 | 0.160 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 307 | 0.160 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1998 | 85 | 0.150 |
Why?
|
Injections, Intravenous | 4 | 2005 | 240 | 0.150 |
Why?
|
GABA Agonists | 3 | 2004 | 20 | 0.150 |
Why?
|
Caspase 3 | 2 | 2012 | 161 | 0.150 |
Why?
|
Tumor Cells, Cultured | 2 | 2010 | 1057 | 0.150 |
Why?
|
Arousal | 1 | 1998 | 170 | 0.150 |
Why?
|
Sheep | 4 | 2001 | 250 | 0.150 |
Why?
|
Medicine, Traditional | 2 | 2016 | 8 | 0.150 |
Why?
|
Rhizome | 2 | 2009 | 6 | 0.150 |
Why?
|
Substance P | 1 | 1997 | 61 | 0.140 |
Why?
|
Diet, High-Fat | 1 | 2017 | 117 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 887 | 0.140 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 2006 | 44 | 0.140 |
Why?
|
Pyrrolidines | 1 | 1996 | 59 | 0.140 |
Why?
|
Cell Line | 2 | 2016 | 2494 | 0.130 |
Why?
|
Metabolomics | 1 | 2016 | 75 | 0.130 |
Why?
|
Affect | 1 | 1998 | 387 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2009 | 780 | 0.130 |
Why?
|
Molecular Conformation | 1 | 2016 | 96 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2014 | 198 | 0.130 |
Why?
|
Vacuoles | 2 | 2013 | 46 | 0.130 |
Why?
|
Insulin | 3 | 2008 | 1146 | 0.130 |
Why?
|
Molecular Docking Simulation | 2 | 2013 | 48 | 0.130 |
Why?
|
Pyridines | 2 | 2013 | 315 | 0.130 |
Why?
|
Analgesics | 1 | 1996 | 119 | 0.130 |
Why?
|
Opioid-Related Disorders | 1 | 1998 | 183 | 0.130 |
Why?
|
Models, Molecular | 3 | 2012 | 1294 | 0.130 |
Why?
|
Adolescent | 5 | 2016 | 9214 | 0.130 |
Why?
|
Superoxides | 2 | 2007 | 74 | 0.130 |
Why?
|
Blood Urea Nitrogen | 1 | 2015 | 34 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2009 | 89 | 0.120 |
Why?
|
Oxonic Acid | 1 | 2014 | 8 | 0.120 |
Why?
|
Xanthine Oxidase | 1 | 2014 | 25 | 0.120 |
Why?
|
Discriminant Analysis | 1 | 2014 | 67 | 0.120 |
Why?
|
Enteritis | 1 | 2014 | 21 | 0.120 |
Why?
|
Malondialdehyde | 1 | 2014 | 26 | 0.120 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 645 | 0.120 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 24 | 0.120 |
Why?
|
Treatment Outcome | 5 | 2015 | 8178 | 0.120 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2007 | 317 | 0.120 |
Why?
|
Energy Metabolism | 2 | 2009 | 276 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 695 | 0.120 |
Why?
|
Feces | 1 | 2016 | 327 | 0.120 |
Why?
|
Boraginaceae | 1 | 2013 | 3 | 0.120 |
Why?
|
Naphthoquinones | 1 | 2013 | 5 | 0.120 |
Why?
|
Ankle Joint | 1 | 2014 | 46 | 0.120 |
Why?
|
Reference Standards | 1 | 2014 | 144 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2014 | 160 | 0.110 |
Why?
|
Canada | 1 | 2014 | 208 | 0.110 |
Why?
|
Prediabetic State | 1 | 2014 | 36 | 0.110 |
Why?
|
Fluoresceins | 2 | 2004 | 43 | 0.110 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 87 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2006 | 385 | 0.110 |
Why?
|
Isoflavones | 1 | 2013 | 13 | 0.110 |
Why?
|
Cyclooxygenase 2 | 1 | 2013 | 99 | 0.110 |
Why?
|
Glucose Intolerance | 1 | 2014 | 94 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 315 | 0.110 |
Why?
|
Iridoids | 1 | 2013 | 2 | 0.110 |
Why?
|
S Phase Cell Cycle Checkpoints | 1 | 2013 | 3 | 0.110 |
Why?
|
Acupuncture Therapy | 2 | 2004 | 10 | 0.110 |
Why?
|
Salvia miltiorrhiza | 1 | 2013 | 3 | 0.110 |
Why?
|
Cyclin B1 | 1 | 2013 | 18 | 0.110 |
Why?
|
Organ Size | 1 | 2014 | 368 | 0.110 |
Why?
|
Hydrogen | 3 | 1998 | 47 | 0.110 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 397 | 0.110 |
Why?
|
rho GTP-Binding Proteins | 1 | 2013 | 55 | 0.110 |
Why?
|
Thymus Gland | 1 | 2014 | 197 | 0.110 |
Why?
|
Action Potentials | 4 | 2001 | 595 | 0.110 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 177 | 0.110 |
Why?
|
Acupuncture Points | 2 | 2003 | 2 | 0.110 |
Why?
|
Membrane Proteins | 2 | 2014 | 1214 | 0.110 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2013 | 30 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 196 | 0.110 |
Why?
|
Knee Joint | 1 | 2014 | 165 | 0.110 |
Why?
|
Spleen | 1 | 2014 | 431 | 0.110 |
Why?
|
Tea | 1 | 2012 | 21 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 172 | 0.110 |
Why?
|
Body Temperature | 2 | 2004 | 124 | 0.110 |
Why?
|
Fasting | 2 | 2004 | 163 | 0.110 |
Why?
|
Species Specificity | 1 | 2014 | 684 | 0.100 |
Why?
|
Annexin A5 | 1 | 2012 | 20 | 0.100 |
Why?
|
United States | 3 | 2014 | 6933 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 93 | 0.100 |
Why?
|
Caspase 9 | 1 | 2012 | 49 | 0.100 |
Why?
|
Enzyme Induction | 1 | 2012 | 88 | 0.100 |
Why?
|
Microdialysis | 1 | 2012 | 32 | 0.100 |
Why?
|
Biotransformation | 1 | 2011 | 50 | 0.100 |
Why?
|
Hydrogen Bonding | 1 | 2012 | 144 | 0.100 |
Why?
|
HIV Infections | 1 | 2001 | 830 | 0.100 |
Why?
|
Catalytic Domain | 1 | 2012 | 156 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2014 | 987 | 0.100 |
Why?
|
Forecasting | 2 | 2003 | 305 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 2013 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2014 | 698 | 0.100 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 114 | 0.100 |
Why?
|
Microscopy, Video | 2 | 2002 | 34 | 0.090 |
Why?
|
Dietary Fats | 1 | 2011 | 135 | 0.090 |
Why?
|
Cell Growth Processes | 1 | 2011 | 85 | 0.090 |
Why?
|
Plant Bark | 1 | 2010 | 5 | 0.090 |
Why?
|
Doxorubicin | 1 | 2011 | 298 | 0.090 |
Why?
|
Middle Aged | 6 | 2016 | 25787 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 94 | 0.090 |
Why?
|
Glucuronates | 1 | 2010 | 22 | 0.090 |
Why?
|
Apigenin | 1 | 2010 | 7 | 0.090 |
Why?
|
Down-Regulation | 1 | 2011 | 519 | 0.090 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2009 | 26 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 312 | 0.090 |
Why?
|
Growth Inhibitors | 1 | 2009 | 42 | 0.090 |
Why?
|
Binding Sites | 1 | 2012 | 1113 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 447 | 0.080 |
Why?
|
Liver | 1 | 2014 | 1204 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 374 | 0.080 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 58 | 0.080 |
Why?
|
Kinetics | 2 | 2002 | 1527 | 0.080 |
Why?
|
Heating | 1 | 2008 | 14 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 555 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2000 | 306 | 0.080 |
Why?
|
Intestines | 1 | 2012 | 416 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 559 | 0.080 |
Why?
|
ErbB Receptors | 1 | 2011 | 500 | 0.080 |
Why?
|
Cyclins | 1 | 2008 | 83 | 0.080 |
Why?
|
Pain Measurement | 2 | 2003 | 328 | 0.080 |
Why?
|
Enkephalin, D-Penicillamine (2,5)- | 2 | 1999 | 3 | 0.080 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 2 | 1999 | 10 | 0.080 |
Why?
|
Cell Membrane | 2 | 2003 | 668 | 0.080 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 2 | 1999 | 22 | 0.080 |
Why?
|
Protein Binding | 1 | 2012 | 1484 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 1708 | 0.080 |
Why?
|
Ethanol | 1 | 2010 | 250 | 0.080 |
Why?
|
Acetylcysteine | 2 | 2010 | 70 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2014 | 1222 | 0.070 |
Why?
|
Picrates | 1 | 2007 | 12 | 0.070 |
Why?
|
Computer Simulation | 1 | 2012 | 1096 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 1146 | 0.070 |
Why?
|
Hydroxyl Radical | 1 | 2007 | 35 | 0.070 |
Why?
|
Hydrazines | 1 | 2007 | 31 | 0.070 |
Why?
|
CD56 Antigen | 1 | 2007 | 18 | 0.070 |
Why?
|
Camellia sinensis | 1 | 2007 | 7 | 0.070 |
Why?
|
Thirst | 1 | 2007 | 19 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2008 | 371 | 0.070 |
Why?
|
Pilot Projects | 2 | 2000 | 865 | 0.070 |
Why?
|
Biphenyl Compounds | 1 | 2007 | 58 | 0.070 |
Why?
|
Chlorogenic Acid | 1 | 2006 | 3 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 1086 | 0.070 |
Why?
|
Severity of Illness Index | 1 | 2013 | 1835 | 0.070 |
Why?
|
Caffeic Acids | 1 | 2006 | 5 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2006 | 243 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 49 | 0.070 |
Why?
|
Burns | 1 | 2008 | 141 | 0.070 |
Why?
|
Cell Shape | 1 | 2006 | 51 | 0.070 |
Why?
|
Uncoupling Agents | 1 | 2006 | 15 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 785 | 0.070 |
Why?
|
Thymidine | 1 | 2006 | 59 | 0.070 |
Why?
|
Reference Values | 2 | 1998 | 661 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 1974 | 0.070 |
Why?
|
Drug Combinations | 1 | 2006 | 201 | 0.070 |
Why?
|
Heart Ventricles | 2 | 2003 | 779 | 0.070 |
Why?
|
Fatigue | 1 | 2007 | 178 | 0.070 |
Why?
|
Zingiberaceae | 2 | 2016 | 9 | 0.070 |
Why?
|
Zanthoxylum | 2 | 2016 | 9 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2009 | 2344 | 0.070 |
Why?
|
Half-Life | 1 | 2005 | 96 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2006 | 425 | 0.060 |
Why?
|
DNA Replication | 1 | 2006 | 170 | 0.060 |
Why?
|
Antidiarrheals | 1 | 2005 | 14 | 0.060 |
Why?
|
Models, Animal | 1 | 2006 | 275 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 2009 | 126 | 0.060 |
Why?
|
Quality of Life | 1 | 2013 | 1661 | 0.060 |
Why?
|
Ondansetron | 1 | 2004 | 21 | 0.060 |
Why?
|
International Normalized Ratio | 1 | 2004 | 39 | 0.060 |
Why?
|
Bicuculline | 1 | 2004 | 18 | 0.060 |
Why?
|
Biofeedback, Psychology | 1 | 2004 | 13 | 0.060 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2004 | 22 | 0.060 |
Why?
|
Microelectrodes | 1 | 2004 | 83 | 0.060 |
Why?
|
Nerve Fibers | 1 | 2004 | 48 | 0.060 |
Why?
|
Cats | 1 | 2004 | 305 | 0.060 |
Why?
|
Young Adult | 1 | 2016 | 6271 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2004 | 389 | 0.060 |
Why?
|
Chickens | 1 | 2004 | 212 | 0.060 |
Why?
|
Iron | 1 | 2004 | 165 | 0.050 |
Why?
|
Axons | 1 | 2004 | 179 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 68 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2003 | 71 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2004 | 190 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 308 | 0.050 |
Why?
|
Glucose Clamp Technique | 1 | 2002 | 39 | 0.050 |
Why?
|
Asteraceae | 1 | 2002 | 4 | 0.050 |
Why?
|
Hydrotherapy | 1 | 2002 | 5 | 0.050 |
Why?
|
Myocardial Reperfusion | 1 | 2002 | 28 | 0.050 |
Why?
|
Hyperphagia | 1 | 2002 | 36 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2003 | 268 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 430 | 0.050 |
Why?
|
Neural Pathways | 1 | 2004 | 318 | 0.050 |
Why?
|
Gastrointestinal Tract | 1 | 2004 | 191 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2002 | 118 | 0.050 |
Why?
|
Garlic | 1 | 2001 | 1 | 0.050 |
Why?
|
Echinacea | 1 | 2001 | 2 | 0.050 |
Why?
|
Hypericum | 1 | 2001 | 2 | 0.050 |
Why?
|
Ginkgo biloba | 1 | 2001 | 5 | 0.050 |
Why?
|
DNA | 1 | 2007 | 1307 | 0.050 |
Why?
|
Dogs | 2 | 2000 | 704 | 0.050 |
Why?
|
Wisconsin | 1 | 2001 | 41 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 428 | 0.050 |
Why?
|
Atropine | 1 | 2001 | 60 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 465 | 0.050 |
Why?
|
Ethnopharmacology | 1 | 2001 | 2 | 0.050 |
Why?
|
Receptors, Cholecystokinin | 1 | 2000 | 1 | 0.050 |
Why?
|
Electric Conductivity | 1 | 2001 | 144 | 0.050 |
Why?
|
Electron Transport | 1 | 2001 | 74 | 0.050 |
Why?
|
Potassium Channels | 1 | 2003 | 343 | 0.050 |
Why?
|
Lidocaine | 1 | 2001 | 65 | 0.050 |
Why?
|
Body Weight Changes | 1 | 2000 | 1 | 0.050 |
Why?
|
Diet | 1 | 2004 | 442 | 0.050 |
Why?
|
Perfusion | 1 | 2002 | 234 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2003 | 353 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2002 | 161 | 0.050 |
Why?
|
Tablets, Enteric-Coated | 1 | 2000 | 6 | 0.050 |
Why?
|
Potassium | 1 | 2001 | 253 | 0.050 |
Why?
|
Drug Design | 1 | 2001 | 124 | 0.050 |
Why?
|
Phenethylamines | 1 | 2000 | 6 | 0.040 |
Why?
|
Sodium Channels | 1 | 2001 | 129 | 0.040 |
Why?
|
Phytosterols | 1 | 1999 | 6 | 0.040 |
Why?
|
Lactulose | 1 | 2000 | 22 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2000 | 46 | 0.040 |
Why?
|
Patch-Clamp Techniques | 1 | 2001 | 396 | 0.040 |
Why?
|
Sodium | 1 | 2001 | 330 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2012 | 638 | 0.040 |
Why?
|
Illinois | 1 | 2001 | 472 | 0.040 |
Why?
|
Nitroarginine | 1 | 1999 | 16 | 0.040 |
Why?
|
Transfection | 1 | 2001 | 911 | 0.040 |
Why?
|
Muscle, Smooth | 2 | 1998 | 354 | 0.040 |
Why?
|
Umbilical Cord | 1 | 1999 | 40 | 0.040 |
Why?
|
Vagotomy | 1 | 1998 | 12 | 0.040 |
Why?
|
Chromatography, Gas | 1 | 1998 | 28 | 0.040 |
Why?
|
Guinea Pigs | 2 | 1997 | 172 | 0.040 |
Why?
|
Piperidines | 1 | 2000 | 164 | 0.040 |
Why?
|
Receptors, GABA-B | 1 | 1998 | 7 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 168 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 1998 | 33 | 0.040 |
Why?
|
Blotting, Western | 2 | 2010 | 794 | 0.040 |
Why?
|
Hirschsprung Disease | 1 | 1998 | 12 | 0.040 |
Why?
|
Cecum | 1 | 1998 | 69 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2000 | 171 | 0.040 |
Why?
|
Muscle Contraction | 2 | 1998 | 284 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 434 | 0.040 |
Why?
|
Sulfonamides | 1 | 2000 | 317 | 0.040 |
Why?
|
Histamine | 1 | 1997 | 126 | 0.040 |
Why?
|
Single-Blind Method | 1 | 1997 | 150 | 0.040 |
Why?
|
Pressure | 1 | 1996 | 165 | 0.030 |
Why?
|
Aging | 1 | 1999 | 713 | 0.030 |
Why?
|
Ubiquitinated Proteins | 1 | 2014 | 4 | 0.030 |
Why?
|
Ileum | 1 | 1995 | 160 | 0.030 |
Why?
|
Bcl-2-Like Protein 11 | 1 | 2014 | 22 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2014 | 77 | 0.030 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2014 | 37 | 0.030 |
Why?
|
Jejunum | 1 | 2014 | 80 | 0.030 |
Why?
|
CD3 Complex | 1 | 2014 | 134 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 247 | 0.030 |
Why?
|
Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2012 | 5 | 0.030 |
Why?
|
Intestine, Small | 1 | 1995 | 299 | 0.030 |
Why?
|
Life Style | 1 | 2014 | 172 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 192 | 0.030 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 72 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 155 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 231 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 43 | 0.030 |
Why?
|
Autophagy | 1 | 2014 | 154 | 0.030 |
Why?
|
Ubiquitination | 1 | 2012 | 71 | 0.030 |
Why?
|
Calcium | 1 | 1997 | 1171 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2012 | 172 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 181 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 283 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2011 | 63 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 160 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 262 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 182 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 370 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.020 |
Why?
|
Caspase Inhibitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 53 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 557 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 699 | 0.020 |
Why?
|
Grape Seed Extract | 1 | 2009 | 4 | 0.020 |
Why?
|
Protective Agents | 1 | 2009 | 33 | 0.020 |
Why?
|
Disease Progression | 1 | 2014 | 1483 | 0.020 |
Why?
|
Peptides | 1 | 2012 | 646 | 0.020 |
Why?
|
Phosphorylation | 1 | 2011 | 1128 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2008 | 102 | 0.020 |
Why?
|
Bacteria | 1 | 2011 | 472 | 0.020 |
Why?
|
Aged | 2 | 2014 | 19019 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 1241 | 0.020 |
Why?
|
Critical Illness | 1 | 2008 | 307 | 0.020 |
Why?
|
Transcription Factors | 1 | 2012 | 1650 | 0.020 |
Why?
|
Models, Biological | 1 | 2009 | 1763 | 0.010 |
Why?
|
Mutation | 1 | 2010 | 4121 | 0.010 |
Why?
|
Myenteric Plexus | 1 | 1998 | 1 | 0.010 |
Why?
|
Rats, Mutant Strains | 1 | 1998 | 23 | 0.010 |
Why?
|
Somatostatin | 1 | 1998 | 53 | 0.010 |
Why?
|
Breeding | 1 | 1998 | 41 | 0.010 |
Why?
|
Emetics | 1 | 1998 | 4 | 0.010 |
Why?
|
Apomorphine | 1 | 1998 | 10 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1998 | 306 | 0.010 |
Why?
|
Fura-2 | 1 | 1997 | 22 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1997 | 64 | 0.010 |
Why?
|
Pedigree | 1 | 1998 | 969 | 0.010 |
Why?
|
Radiography | 1 | 1998 | 809 | 0.010 |
Why?
|
Biomarkers | 1 | 1998 | 1753 | 0.010 |
Why?
|